Becton Dickinson & Co
(MIL:1BDX)
€
211.5
-2.1 (-0.98%)
Market Cap: 60.75 Bil
Enterprise Value: 77.74 Bil
PE Ratio: 37.37
PB Ratio: 2.48
GF Score: 64/100 Becton Dickinson and Co at Cowen Health Care Conference (Virtual) Transcript
Mar 07, 2022 / 02:50PM GMT
Joshua Thomas Jennings
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Good morning. I'm Josh Jennings from the Cowen Medical Devices team, and we're continuing down our med devices track at the 42nd Annual Cowen Healthcare Conference. We are thrilled to have David Hickey, the Executive Vice President of Becton, Dickinson and President of the Life Sciences segment joining us here this morning to give us some access and some time to dig into his business unit and learn a little bit more about the IDS and Biosciences franchises.
David, good morning, and thanks so much for joining us today.
David Hickey
Becton, Dickinson and Company - Executive VP & President of Life Sciences Segment
Joshua, pleasure to be here. Thank you for having me. Looking forward to the discussion.
Questions & Answers
Joshua Thomas Jennings
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Excellent. So we learned a lot at the Investor Day and then your team did
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot